Normunity is a biotechnology company developing anti-cancer therapies that target novel tumor-specific mechanisms to engage T cells and suppress immune evasion in solid tumors.

Aviceda Therapeutics is a biotech company developing next-generation immunomodulators for ophthalmic conditions using its proprietary HALOS™ nanotechnology platform.

OrsoBio, Inc. is a clinical-stage biopharmaceutical company developing novel mitochondrial protonophore therapies targeting obesity and associated metabolic disorders.

Sudo Biosciences is a biopharmaceutical company developing TYK2 inhibitor candidates for the treatment of multiple sclerosis, neurodegenerative, and immune-mediated dermatologic diseases.

OrsoBio, Inc. is a clinical-stage biopharmaceutical company developing novel mitochondrial protonophore therapies targeting obesity and associated metabolic disorders.